Immunoprophylaxis for respiratory syncytial virus

Pediatr Infect Dis J. 2002 May;21(5):473-8. doi: 10.1097/00006454-200205000-00036.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents / therapeutic use*
  • Child, Preschool
  • Cost of Illness
  • Hospitalization
  • Humans
  • Immunoglobulins, Intravenous*
  • Infant
  • Infant, Newborn
  • Palivizumab
  • Practice Guidelines as Topic
  • Respiratory Syncytial Virus Infections / complications
  • Respiratory Syncytial Virus Infections / prevention & control*
  • Risk Assessment

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Immunoglobulins, Intravenous
  • Palivizumab